These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 761943)

  • 21. Eradication of lymphoma cells with allogeneic immune peritoneal cells.
    Dullens HF; den Otter W
    Experientia; 1973 Apr; 29(4):479-81. PubMed ID: 4708353
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunological enhancement of a murine allogeneic lymphoma.
    Pasqualini CD; Colmerauer ME
    Medicina (B Aires); 1976; 36(3):189-92. PubMed ID: 966987
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunological characteristics of leukemia and lymphoma in allogeneic cell immunity: growth of syngeneic tumors in rats immunized with allogeneic cells.
    Hosokawa M; Yamashita T; Gotohda E; Takeichi N; Kodama T; Kobayashi H
    Int J Cancer; 1978 Jul; 22(1):91-7. PubMed ID: 681026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VIII. Expression and shedding of Fc gamma receptors on metastatic tumor cell variants.
    Schirrmacher V; Jacobs W
    J Supramol Struct; 1979; 11(1):105-11. PubMed ID: 522481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

  • 26. Host response during the latent period and the growth of an immunologically induced mouse lymphoma.
    Krüger GR
    Beitr Pathol; 1972 May; 146(2):132-44. PubMed ID: 5068499
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. II. Influence of minor histocompatibility antigens on tumor resistance, gamma-interferon induction and cytotoxic response.
    Schirrmacher V; Landolfo S; Zawatzky R; Kirchner H
    Invasion Metastasis; 1981; 1(3):175-94. PubMed ID: 6821364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Site-dependent differences in rejection of tumor cells with and without preimmunization.
    den Otter W; Runhaar BA; Ruitenbeek A; Dullens HF
    Eur J Immunol; 1974 Jun; 4(6):444-6. PubMed ID: 4471634
    [No Abstract]   [Full Text] [Related]  

  • 29. Induction of malignant lymphomas by N,N'-dimethylnitrosourea in adult mice.
    Hiraki S
    Gan; 1971 Apr; 62(2):135-7. PubMed ID: 5114630
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship of cellular proliferation and the generation of cytotoxic cells in an in vitro secondary immune response to syngeneic rat lymphoma cells.
    Bernstein ID; Cohen EF; Wright PW
    J Immunol; 1977 Mar; 118(3):1090-4. PubMed ID: 845434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spontaneous shedding and antibody induced modulation of histocompatibility antigens on murine lymphomata: Correlation with metastic capacity.
    Davey GC; Currie GA; Alexander P
    Br J Cancer; 1976 Jan; 33(1):9-14. PubMed ID: 1252330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological response in the mouse brain: I. Transplantation immunity to mouse lymphoma graft.
    Keyaki A; Handa H; Yamashita J; Kuribayashi K; Masuda T
    Nihon Geka Hokan; 1988 May; 57(3):191-201. PubMed ID: 3248016
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor cell-related syngeneic skin graft rejection in gross leukemia.
    Mariani T; Maruyama Y; Good RA
    Natl Cancer Inst Monogr; 1972 Dec; 35():309-20. PubMed ID: 4572830
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of immune responses to spontaneous hamster lymphomas.
    Vasa-Thomas KA; Ambrose KR; Bellomy BB; Coggin JH
    J Natl Cancer Inst; 1977 May; 58(5):1287-93. PubMed ID: 67210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract]   [Full Text] [Related]  

  • 36. Destruction of murine lymphoma cells by allogeneic immune peritoneal macrophages in vitro: an ultrastructure study.
    Dingemans KP; Pels E; Den Otter W
    J Natl Cancer Inst; 1981 Jan; 66(1):67-79. PubMed ID: 6935467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinogenicity of tumor cell populations: origin of a putative H-2 isoantigenic loss variant tumor.
    Kerbel RS; Florian M; Man MS; Dennis J; McKenzie IF
    J Natl Cancer Inst; 1980 May; 64(5):1221-30. PubMed ID: 6929020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):615-26. PubMed ID: 5084104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenicity and immunogenicity associated with membranes isolated from cell-free ascites fluid of lymphoma-bearing mice.
    Raz A; Barzilai R; Spira G; Inbar M
    Cancer Res; 1978 Aug; 38(8):2480-5. PubMed ID: 667843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.